Capnography During Percutaneous Endoscopic Gastrostomy (PEG)

Clinical Value of Advanced Patient Monitoring Using Capnography With Analysis of the Integrated Pulmonary Index During Percutaneous Endoscopic Gastrostomy.

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01242358

Acronym

PEG

Enrollment

170

Registered

2010-11-17

Start date

2010-06-30

Completion date

2012-03-31

Last updated

2011-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In the Study the Value of Capnography for Avoiding Complications During Sedation for PEG is Evaluated.

Keywords

hypoxaemia - capnography - integrated pulmonary index - PEG

Brief summary

In this randomized controlled trial the utility of capnography gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Interventions

DEVICECapnography

Capnographic monitoring

DEVICEStandard monitoring

Standard monitoring

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* 18 Years and older * Scheduled for PEG with propofol sedation

Exclusion criteria

* No informed consent * ASA V * Emergency endoscopy * Preexisting hypotension, bradycardia or hypoxemia

Design outcomes

Primary

Measure	Time frame
Hypoxemia	From the beginning to the end of the PEG procedure, i.e. from 0h to approximately 2h

Secondary

Measure	Time frame
Further complications	From the beginning to the end of the PEG procedure, i.e. from 0h to approximately 2h

Countries

Germany

Contacts

Primary ContactAndrea Riphaus, MD

ariphaus@web.de+49-234-299

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026